Abstract
This report analyzes the worldwide markets for Blood Banking & Blood Products
in Millions of US$. The specific product segments analyzed are Blood
Components and Plasma Products (Whole Blood & Cellular Components, & Plasma
Fractions), and Equipment, Blood Tests and Other Consumables (Includes blood
screening and related QC function, but excludes patient diagnosis). The report
provides separate comprehensive analytics for the US, Canada, Japan, Europe,
Asia-Pacific, Latin America, and Rest of World. Annual forecasts are provided
for each region for the period of 2001 through 2015. A ten-year historic
analysis is also provided for these markets with annual market analytics. The
report profiles 144 companies including many key and niche players worldwide
such as America' s Blood Centers, AABB, American Red Cross, CorCell Inc., Japan
Red Cross, LifeBank Cryogenics, National Blood Foundation, New England Cord
Blood Bank, Inc., New York Blood Center, The Cord Blood Registry, VITA 34 AG,
Beckman Coulter Inc, Becton Dickinson, Bio Products Laboratory, Chiron
Corporation, CSL Behring, Daxor Corporation, Fresenius Group, Gambro BCT,
Gen-Probe Incorporated, Grifols, Haemonetics, Hemagen Diagnostics Inc.,
Immucor Inc., Kawasumi Laboratories, Inc., Olympus America, Inc., PharmaStem
Therapeutics, Inc., Terumo Corporation, ThermoGenesis Corp., and ZymeQuest,
Inc. Market data and analytics are derived from primary and secondary
research. Company profiles are mostly extracted from URL research and reported
select online sources.